|
Contact: Guillermo de la Vega (201) 847-7017 Franklin Lakes, NJ (March 13, 1998) -- Becton Dickinson and Company, maker of the B-D™ ULTRA-FINE™ insulin syringe, has introduced the B-D™ ULTRA-FINE™ II lancet, a new product specifically designed to minimize the discomfort associated with blood glucose self-testing. The B-D ULTRA-FINE II lancet is the thinnest lancet available (30 gauge), with a unique cylindrical shape that makes it easier for people to use. The B-D ULTRA-FINE II lancet was shown to be significantly less painful than other lancets tested in clinical trials *. In fact, 81% of the patients preferred the B-D ULTRA-FINE II lancet over their current lancet*. For patient convenience, the B-D ULTRA-FINE II lancet is compatible with most lancing devices available on the market today, including the B-D adjustable tip lancet device. Guillermo de la Vega, Product Manager, Blood Sampling, said, "The thinner gauge is only half the story. There are several features that set this lancet apart from others on the market. The B-D ULTRA-FINE II lancet is manufactured by injection molding, a process that allows 100% needle point inspection. Finally, a high quality stylet is achieved through electro-polishing. This is the same BD technology used to remove microscopic fragments from syringe needles, which improves smoothness and reduces penetration force." BD is distributing over 3 million samples of the B-D ULTRA-FINE II lancet through in-pack and direct-to-consumer programs, and via its website at www.bd.com/diabetes. Consumers and health care professionals may also obtain free samples by calling 1-800-385-6221. Becton Dickinson and Company is a worldwide leader in diabetes healthcare. The company manufactures and markets a broad range of insulin delivery devices and services to benefit patients and health care professionals. * Data on file at Becton Dickinson
|